Clinical trialNCT05815173RecruitingPhase 1Interventional

Ladarixin With Sotorasib in Advanced NSCLC

SponsorNYU Langone HealthEnrollment40Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced KRASG12C mutant non-small cell lung cancer (NSCLC).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Salman Punekar, MD
NYU Langone Health
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Nyu Langone Health
Garden City, New York, United States
Recruiting
Nyu Langone Health
Mineola, New York, United States
Recruiting
Nyu Langone Health
New Hyde Park, New York, United States
Recruiting
Nyu Langone Health
New York, New York, United States
Recruiting
Nyu Langone Health
New York, New York, United States
Recruiting
Nyu Langone Health
New York, New York, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LadarixinSotorasib →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Aug 2023
Primary completion: 31 Aug 2027
Completion: 31 Aug 2027
Last update posted: 30 Dec 2025
Registered enrollment: 40
Registry id: NCT05815173

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.